IP Library Granted Patent US 8,039,257
Granted Patent B2
US 8,039,257 · App. 12/897,297 · Granted Oct 18, 2011

Pre-transplant accomodated organs resistant to anti-donor immunity

Assignee: The Board of Regents of the University of Nebraska
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,257
App. No.
12/897,297
Granted
Oct 18, 2011
Kind
B2
Abstract

This invention includes the composition of organ grafts accommodated prior to transplantation and therefore resistant to rejection by preformed antibodies. Accommodation is achieved within the donor animal by administration of sub-lethal levels of accommodation inducing factors derived from animals sensitized to the donor.

Claims (12)

1. A method for providing a tissue or organ resistant to complement-dependent cytotoxicity mediated by preformed antibodies reactive with donor antigen in a sensitized recipient mammal, comprising the steps of:

(i) infusing a first donor mammal at least one time with sub-lethal levels of bone marrow from a sensitized recipient mammal,

(ii) administering a tissue or organ from a second donor mammal to the first donor mammal;

(iii) allowing prolonged exposure of the first donor mammal to the bone marrow,

(iv) harvesting the tissue or organ of the second donor mammal from the first donor mammal; and

(v) determining that the tissue or organ of the second donor mammal is resistant to complement-dependent cytotoxicity mediated by preformed antibodies of the sensitized recipient mammal reactive with donor antigen,

wherein the method does not include administering an accommodation-inducing factor other than bone marrow; and

wherein the first donor mammal is a non-human pre-immune fetal donor mammal.

2. The method of claim 1 , wherein the sensitized recipient mammal is a human.

3. The method of claim 1 wherein step (ii) is performed after step (i).

4. The method of claim 1 wherein the method provides the organ and the organ is selected from the group consisting of heart, kidney, lung, liver, pancreas, intestine, spleen, and thymus.

5. The method of claim 1 , wherein the method provides the tissue and the tissue is selected from the group consisting of bone, skin, neural tissue, skeletal muscle myocytes, smooth muscle myocytes, cardiac muscle myocytes, pancreatic islets, hepatocytes, stem cells, progenitor cells, and hematopoietic cells.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2011
From: BESCHORNER, WILLIAM E
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 025802/0891 →
CONFIRMATORY LICENSE Recorded Dec 6, 2010
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025444/0993 →
Continuity (3)
Division 10181896
Provisional Application 60178347 · Jan 25, 2000
Related Publication 20110020295A1 · Jan 27, 2011